Drug Shortage Report for NOVAMOXIN
Report ID | 207503 |
Drug Identification Number | 00452130 |
Brand name | NOVAMOXIN |
Common or Proper name | AMOXICILLIN SUS 250MG/5ML |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | AMOXICILLIN |
Strength(s) | 250MG |
Dosage form(s) | GRANULES FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J01CA |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-01-01 |
Estimated end date | 2024-03-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v40 | 2024-03-18 | French | Compare |
v39 | 2024-03-18 | English | Compare |
v38 | 2024-03-07 | French | Compare |
v37 | 2024-03-07 | English | Compare |
v36 | 2024-02-29 | French | Compare |
v35 | 2024-02-29 | English | Compare |
v34 | 2024-02-22 | French | Compare |
v33 | 2024-02-22 | English | Compare |
v32 | 2024-02-08 | French | Compare |
v31 | 2024-02-08 | English | Compare |
v30 | 2024-02-01 | French | Compare |
v29 | 2024-02-01 | English | Compare |
v28 | 2024-01-25 | French | Compare |
v27 | 2024-01-25 | English | Compare |
v26 | 2024-01-22 | French | Compare |
v25 | 2024-01-22 | English | Compare |
v24 | 2024-01-18 | French | Compare |
v23 | 2024-01-18 | English | Compare |
v22 | 2024-01-15 | French | Compare |
v21 | 2024-01-15 | English | Compare |